LOGOLOGOLOGOLOGO
  • About us
    • What we do
    • Who we are
      • Governance
      • Staff
      • Vacancies
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Patient BioForum
      • Study – Impact of the EU’s General Pharmaceutical Legislation
    • Industrial Biotechnology Council
      • EFIB
      • Microorganisms
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
      • Biotechnology in our Lives
  • Activities
    • 25 Years of Innovation
    • The EU Biotech Act
    • European Biotech Week
    • EU Projects
      • PRIMED Project
      • APROVALS Project
  • News & Events
    • News
    • Events
  • Library
Become a member
✕

EuropaBio comments on the Circular Economy Action Plan

20/01/2020
OTHER

EuropaBio comments on the Circular Economy Action Plan

EuropaBio welcomes the foreseen new Circular Economy Action Plan and the plan to publish it with the Industrial Strategy. Industrial biotechnology is a central pillar of innovation in Europe and one of Europe’s Key Enabling Technologies (KETs). It enables development of smarter, more sustainable products and processes, based on renewable raw materials, which make better use of natural resources, adding value in the process and helping to reduce GHG emissions.

Europe needs strong policy signals, measures and incentives, consolidated through its circular economy strategy, in order to engage industry in the creation of smarter products, processes and partnerships. It is important to ensure the development of a coherent, holistic, supportive policy for the circular economy and for bio-based industries along the value-chain and integrate bioeconomy and circular economy throughout EU policies. Biorefineries, where industrial biotechnology helps convert renewable feedstocks (which can include municipal solid waste, agricultural and forestry waste) into everyday products, are at the centre of the circular economy. The biorefinery model has an important role to play in contributing to ‘zero waste’ objectives. It will also be important to further explore the efficient use of novel biomass and future potential wastes and residues as important resources for developing the bioeconomy.

With industrial biotechnology also other materials can be recovered from organic wastes (lg. carbon or phosphates) and from sludges in biorefineries. With a view to the commercialisation of innovative bio-based products produced in biorefineries, it will be important to have ‘end of waste’ certification and standards in place.

We believe that the bioeconomy should be included in the future EU Circular Economy Action Plan, since the combination of both could boost the achievement of EU ambitions in fields such as climate, resource efficiency and waste.

Bio-based plastics, produced from biomass, help to decrease our dependence on fossil carbon resources and can offer significant CO2 emissions savings. Biodegradable and compostable plastics are designed for specific applications where recycling is not an option when for example items are soiled, and can also offer a key advantage when it comes to the logistics of bio-waste recycling from households. According to the revised Waste Framework Directive, separate collection of bio-waste will be mandatory by end 2023, and thus it is expected that there will be more waste to be efficiently processed or recycled organically, thanks to home or industrial composting systems.

However, we are concerned the generic definition of "biodegradable" can be confusing. Currently, Directive 94/62/EC established the principle of ‘organic recycling’, which makes use of biodegradability of packaging. However, in points 3c and 3d of Annex II with the definitions of essential requirements a differentiation is made between recoverable packaging in the form of compost (3c) and biodegradable packaging (3d), which can generate the erroneous idea that ‘biodegradable packaging’ is different from ‘compostable packaging’. The corresponding harmonised standard EN 13432 requires conformity to the essential requirements for packaging with regard to biodegradable packaging recoverable in the form of compost in accordance with the European Directive. Therefore, clear definitions in the legislation are important.

In relation to forthcoming initiatives on packaging and waste, we believe that the benefits of using renewable resources for the manufacturing of packaging should also be reflected and equally promoted compared to recycled content.

EuropaBio welcomes the intention to address enabling conditions, such as innovation and investment opportunities for circular business models and enabling technologies. Furthermore, EuropaBio supports the continuation of an ambitious public-private partnership on circular bio-based industries, building on the BBI JU’s successes.

EuropaBio comments on the Circular Economy Action Plan


Download
Share
Alexandra Simionca
Alexandra Simionca

Related posts

03/07/2025

Life Sciences Strategy Embraces Biotech for Global Impact


Read more
26/06/2025

EuropaBio AGM 2025: Association Chair, Executive Committee and Board announced


Read more
25/06/2025

Hawkwood Biotech joins EuropaBio: Supporting Industrial Biotech with their Critical Challenges


Read more

Important links

  • EuropaBio Position on the Critical Medicines Act
  • Life Sciences Strategy Embraces Biotech for Global Impact

Categories in our Newsroom

EBIO-white

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2025 Europabio. All Rights Reserved. Designed by EYAS
Become a member

Algal Omega 3

Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

Cheese

Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.

Clothes

Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

Vitamin B2

The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

Detergents

Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

Insulin

Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.